Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    G01 - Progress in Lung Cancer: Celebrating 40 Years of IASLC and Research Progress

    • Type: Other Sessions
    • Track: Other Topics
    • Presentations: 4
    • Moderators:T. Mok
    • Coordinates: 10/27/2013, 17:30 - 18:30, Parkside Auditorium, Level 1
    • +

      G01.3 - Biology and Pathology

      18:00 - 18:15  |  Author(s): F. Hirsch

      • Abstract

      No abstract available for this presentation

  • +

    PL01 - Opening Plenary

    • Type: Plenary Session
    • Track: Prevention & Epidemiology
    • Presentations: 2
    • Moderators:M. Boyer
    • Coordinates: 10/27/2013, 18:45 - 20:15, Plenary Hall, Ground Level
    • +

      PL01.01 - 40 Years IASLC

      18:45 - 18:45  |  Author(s): F. Hirsch

      • Abstract

      No abstract available for this presentation

  • +

    P1.06 - Poster Session 1 - Prognostic and Predictive Biomarkers

    • Type: Poster Session
    • Track: Biology
    • Presentations: 59
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.06-004 - ROS1 Immunohistochemistry Among Major Genotypes of Non-Small Cell Lung Carcinoma

      09:30 - 09:30  |  Author(s): T. Boyle

      • Abstract

      Loading...

  • +

    O01 - Prognostic and Predictive Biomarkers I

    • Type: Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 8
    • Moderators:T. Mitsudomi
    • Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Auditorium, Level 1
    • +

      O01.07 - Randomized Proteomic Stratified Phase III Study of Second Line Erlotinib (E) versus Chemotherapy (CT) in Patients with Inoperable Non-Small Cell Lung Cancer (PROSE): Secondary Endpoint Analysis

      11:35 - 11:45  |  Author(s): V. Gregorc

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    O04 - Molecular Pathology I

    • Type: Oral Abstract Session
    • Track: Pathology
    • Presentations: 8
    • Moderators:I.I. Wistuba
    • Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Ballroom A, Level 1
    • +

      O04.06 - An international standardization study using the ALK IHC antibody D5F3 and a sensitive detection kit demonstrates high concordance between ALK IHC and ALK FISH and between evaluators

      11:25 - 11:35  |  Author(s): M.W. Wynes

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MO05 - Prognostic and Predictive Biomarkers II

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 12
    • Moderators:J. Hu
    • Coordinates: 10/28/2013, 16:15 - 17:45, Parkside Auditorium, Level 1
    • +

      MO05.02 - Overexpression of FGFR1 mRNA and protein are more frequent than FGFR1 gene amplification in non-small cell lung cancer (NSCLC) patients

      16:20 - 16:25  |  Author(s): M.W. Wynes

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    PC02 - EGFR as a Target in Early Stage Disease

    • Type: Pro/Con Session
    • Track: Medical Oncology
    • Presentations: 5
    • Moderators:N. Pavlakis
    • Coordinates: 10/29/2013, 14:00 - 15:30, Parkside Auditorium, Level 1
  • +

    MO18 - NSCLC - Targeted Therapies IV

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 13
    • Moderators:L. Horn
    • Coordinates: 10/29/2013, 16:15 - 17:45, Bayside Auditorium B, Level 1
  • +

    P3.18 - Poster Session 3 - Pathology

    • Type: Poster Session
    • Track: Pathology
    • Presentations: 21
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.18-012 - The hidden 50% of the ALK positive NSCLC patients

      09:30 - 09:30  |  Author(s): M. Pekar

      • Abstract

      Loading...